Logo image of OGI

ORGANIGRAM GLOBAL INC (OGI) Stock Fundamental Analysis

NASDAQ:OGI - CA68617J1003 - Common Stock

1.63 USD
-0.02 (-1.21%)
Last: 9/8/2025, 12:20:33 PM
Fundamental Rating

3

OGI gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 195 industry peers in the Pharmaceuticals industry. OGI may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, OGI is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

OGI had negative earnings in the past year.
OGI had a positive operating cash flow in the past year.
In the past 5 years OGI always reported negative net income.
OGI had negative operating cash flow in 4 of the past 5 years.
OGI Yearly Net Income VS EBIT VS OCF VS FCFOGI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M -150M -200M

1.2 Ratios

The Return On Assets of OGI (1.38%) is better than 83.08% of its industry peers.
OGI's Return On Equity of 2.02% is amongst the best of the industry. OGI outperforms 83.08% of its industry peers.
Industry RankSector Rank
ROA 1.38%
ROE 2.02%
ROIC N/A
ROA(3y)-32.3%
ROA(5y)-30.36%
ROE(3y)-36.4%
ROE(5y)-36.38%
ROIC(3y)N/A
ROIC(5y)N/A
OGI Yearly ROA, ROE, ROICOGI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

OGI has a better Profit Margin (3.47%) than 82.56% of its industry peers.
The Operating Margin and Gross Margin are not available for OGI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 3.47%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OGI Yearly Profit, Operating, Gross MarginsOGI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

More info and screens

3

2. Health

2.1 Basic Checks

OGI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, OGI has more shares outstanding
Compared to 5 years ago, OGI has more shares outstanding
OGI has a worse debt/assets ratio than last year.
OGI Yearly Shares OutstandingOGI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
OGI Yearly Total Debt VS Total AssetsOGI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

Based on the Altman-Z score of -0.38, we must say that OGI is in the distress zone and has some risk of bankruptcy.
OGI has a Altman-Z score of -0.38. This is comparable to the rest of the industry: OGI outperforms 49.23% of its industry peers.
OGI has a Debt/Equity ratio of 0.14. This is a healthy value indicating a solid balance between debt and equity.
OGI has a Debt to Equity ratio of 0.14. This is comparable to the rest of the industry: OGI outperforms 49.23% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Altman-Z -0.38
ROIC/WACCN/A
WACC9.29%
OGI Yearly LT Debt VS Equity VS FCFOGI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

A Current Ratio of 2.59 indicates that OGI has no problem at all paying its short term obligations.
OGI's Current ratio of 2.59 is in line compared to the rest of the industry. OGI outperforms 47.69% of its industry peers.
A Quick Ratio of 1.42 indicates that OGI should not have too much problems paying its short term obligations.
OGI has a Quick ratio of 1.42. This is in the lower half of the industry: OGI underperforms 62.05% of its industry peers.
Industry RankSector Rank
Current Ratio 2.59
Quick Ratio 1.42
OGI Yearly Current Assets VS Current LiabilitesOGI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

6

3. Growth

3.1 Past

OGI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 98.88%, which is quite impressive.
Looking at the last year, OGI shows a very strong growth in Revenue. The Revenue has grown by 38.86%.
OGI shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.73% yearly.
EPS 1Y (TTM)98.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-253.85%
Revenue 1Y (TTM)38.86%
Revenue growth 3Y26.37%
Revenue growth 5Y14.73%
Sales Q2Q%72.41%

3.2 Future

OGI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.86% yearly.
Based on estimates for the next years, OGI will show a quite strong growth in Revenue. The Revenue will grow by 17.78% on average per year.
EPS Next Y119.5%
EPS Next 2Y42.05%
EPS Next 3Y28.91%
EPS Next 5Y19.86%
Revenue Next Year55.97%
Revenue Next 2Y33.69%
Revenue Next 3Y26.12%
Revenue Next 5Y17.78%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
OGI Yearly Revenue VS EstimatesOGI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 100M 200M 300M 400M
OGI Yearly EPS VS EstimatesOGI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 -0.5 -1 -1.5 -2 -2.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Forward Earnings ratio of 296.88 indicates a quite expensive valuation of OGI.
Based on the Price/Forward Earnings ratio, OGI is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
OGI is valuated expensively when we compare the Price/Forward Earnings ratio to 22.69, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 296.88
OGI Price Earnings VS Forward Price EarningsOGI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OGI Per share dataOGI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates OGI does not grow enough to justify the current Price/Earnings ratio.
OGI's earnings are expected to grow with 28.91% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.05%
EPS Next 3Y28.91%

More info and screens

0

5. Dividend

5.1 Amount

OGI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ORGANIGRAM GLOBAL INC

NASDAQ:OGI (9/8/2025, 12:20:33 PM)

1.63

-0.02 (-1.21%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)08-13 2025-08-13/bmo
Earnings (Next)12-16 2025-12-16/amc
Inst Owners5.59%
Inst Owner Change18.4%
Ins Owners2.47%
Ins Owner ChangeN/A
Market Cap218.96M
Analysts77.5
Price Target2.22 (36.2%)
Short Float %6.11%
Short Ratio7.04
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)376.4%
Min EPS beat(2)-164.03%
Max EPS beat(2)916.83%
EPS beat(4)1
Avg EPS beat(4)56.27%
Min EPS beat(4)-400%
Max EPS beat(4)916.83%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)4.51%
Min Revenue beat(2)3.01%
Max Revenue beat(2)6%
Revenue beat(4)3
Avg Revenue beat(4)-0.06%
Min Revenue beat(4)-12.23%
Max Revenue beat(4)6%
Revenue beat(8)5
Avg Revenue beat(8)1.52%
Revenue beat(12)6
Avg Revenue beat(12)-1.43%
Revenue beat(16)9
Avg Revenue beat(16)0.17%
PT rev (1m)7.18%
PT rev (3m)6%
EPS NQ rev (1m)-25%
EPS NQ rev (3m)50%
EPS NY rev (1m)138.4%
EPS NY rev (3m)138.4%
Revenue NQ rev (1m)5.13%
Revenue NQ rev (3m)4.9%
Revenue NY rev (1m)1.78%
Revenue NY rev (3m)5.22%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 296.88
P/S 1.35
P/FCF N/A
P/OCF 109.69
P/B 0.78
P/tB 1.07
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)0.01
Fwd EY0.34%
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)0.01
OCFY0.91%
SpS1.21
BVpS2.08
TBVpS1.52
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.38%
ROE 2.02%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 3.47%
GM N/A
FCFM N/A
ROA(3y)-32.3%
ROA(5y)-30.36%
ROE(3y)-36.4%
ROE(5y)-36.38%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 122.48%
Cap/Sales 8.8%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.59
Quick Ratio 1.42
Altman-Z -0.38
F-Score3
WACC9.29%
ROIC/WACCN/A
Cap/Depr(3y)118.74%
Cap/Depr(5y)166.77%
Cap/Sales(3y)18.54%
Cap/Sales(5y)32.36%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)98.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-253.85%
EPS Next Y119.5%
EPS Next 2Y42.05%
EPS Next 3Y28.91%
EPS Next 5Y19.86%
Revenue 1Y (TTM)38.86%
Revenue growth 3Y26.37%
Revenue growth 5Y14.73%
Sales Q2Q%72.41%
Revenue Next Year55.97%
Revenue Next 2Y33.69%
Revenue Next 3Y26.12%
Revenue Next 5Y17.78%
EBIT growth 1Y-79.26%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year134.97%
EBIT Next 3Y49.25%
EBIT Next 5Y30.42%
FCF growth 1Y78.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y106.64%
OCF growth 3YN/A
OCF growth 5YN/A